9 Patents
- US125775622026Treatment of Glaucoma with Rho Guanine Nucleotide Exchange Factor 12 (ARHGEF12) Inhibitors
Regeneron Pharmaceuticals, Inc.
0 cites - US123702572025Materials and Methods of Treating Mhc-i-opathy Risk Haplotypes
Regeneron Pharmaceuticals, Inc.
0 cites - US122586272025Kelch Domain Containing 7B (KLHDC7B) Variants and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - US121578912024Treatment of Uveitis with Endoplasmic Reticulum Aminopeptidase 1 (ERAP1) Inhibitors
Regeneron Pharmaceuticals, Inc.
0 cites - US118651342024Treatment of Inflammation with Glucocorticoids and Angiopoietin-like 7 (ANGPTL7) Inhibitors
Regeneron Pharmaceuticals, Inc.
0 cites - US118459892023Treatment of Ophthalmic Conditions with Angiopoietin-like 7 (ANGPTL7) Inhibitors
Regeneron Pharmaceuticals, Inc.
0 cites - US118209822023Treatment of Ophthalmic Conditions with Son of Sevenless 2 (SOS2) Inhibitors
Regeneron Pharmaceuticals, Inc.
0 cites - US117675262023Treatment of Ophthalmic Conditions with Angiopoietin-like 7 (ANGPTL7) Inhibitors
Regeneron Pharmaceuticals, Inc.
0 cites - US116741772023Kelch Domain Containing 7B (KLHDC7B) Variants and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites